Skip to main content

A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.

Publication ,  Journal Article
Mehra, MR; Naka, Y; Uriel, N; Goldstein, DJ; Cleveland, JC; Colombo, PC; Walsh, MN; Milano, CA; Patel, CB; Jorde, UP; Pagani, FD; Aaronson, KD ...
Published in: N Engl J Med
February 2, 2017

BACKGROUND: Continuous-flow left ventricular assist systems increase the rate of survival among patients with advanced heart failure but are associated with the development of pump thrombosis. We investigated the effects of a new magnetically levitated centrifugal continuous-flow pump that was engineered to avert thrombosis. METHODS: We randomly assigned patients with advanced heart failure to receive either the new centrifugal continuous-flow pump or a commercially available axial continuous-flow pump. Patients could be enrolled irrespective of the intended goal of pump support (bridge to transplantation or destination therapy). The primary end point was a composite of survival free of disabling stroke (with disabling stroke indicated by a modified Rankin score >3; scores range from 0 to 6, with higher scores indicating more severe disability) or survival free of reoperation to replace or remove the device at 6 months after implantation. The trial was powered for noninferiority testing of the primary end point (noninferiority margin, -10 percentage points). RESULTS: Of 294 patients, 152 were assigned to the centrifugal-flow pump group and 142 to the axial-flow pump group. In the intention-to-treat population, the primary end point occurred in 131 patients (86.2%) in the centrifugal-flow pump group and in 109 (76.8%) in the axial-flow pump group (absolute difference, 9.4 percentage points; 95% lower confidence boundary, -2.1 [P<0.001 for noninferiority]; hazard ratio, 0.55; 95% confidence interval [CI], 0.32 to 0.95 [two-tailed P=0.04 for superiority]). There were no significant between-group differences in the rates of death or disabling stroke, but reoperation for pump malfunction was less frequent in the centrifugal-flow pump group than in the axial-flow pump group (1 [0.7%] vs. 11 [7.7%]; hazard ratio, 0.08; 95% CI, 0.01 to 0.60; P=0.002). Suspected or confirmed pump thrombosis occurred in no patients in the centrifugal-flow pump group and in 14 patients (10.1%) in the axial-flow pump group. CONCLUSIONS: Among patients with advanced heart failure, implantation of a fully magnetically levitated centrifugal-flow pump was associated with better outcomes at 6 months than was implantation of an axial-flow pump, primarily because of the lower rate of reoperation for pump malfunction. (Funded by St. Jude Medical; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755 .).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 2, 2017

Volume

376

Issue

5

Start / End Page

440 / 450

Location

United States

Related Subject Headings

  • Young Adult
  • Thrombosis
  • Stroke
  • Prosthesis Failure
  • Prosthesis Design
  • Middle Aged
  • Kaplan-Meier Estimate
  • Intention to Treat Analysis
  • Humans
  • Heart-Assist Devices
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mehra, M. R., Naka, Y., Uriel, N., Goldstein, D. J., Cleveland, J. C., Colombo, P. C., … MOMENTUM 3 Investigators, . (2017). A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med, 376(5), 440–450. https://doi.org/10.1056/NEJMoa1610426
Mehra, Mandeep R., Yoshifumi Naka, Nir Uriel, Daniel J. Goldstein, Joseph C. Cleveland, Paolo C. Colombo, Mary N. Walsh, et al. “A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.N Engl J Med 376, no. 5 (February 2, 2017): 440–50. https://doi.org/10.1056/NEJMoa1610426.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, et al. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 Feb 2;376(5):440–50.
Mehra, Mandeep R., et al. “A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.N Engl J Med, vol. 376, no. 5, Feb. 2017, pp. 440–50. Pubmed, doi:10.1056/NEJMoa1610426.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C, MOMENTUM 3 Investigators. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 Feb 2;376(5):440–450.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

February 2, 2017

Volume

376

Issue

5

Start / End Page

440 / 450

Location

United States

Related Subject Headings

  • Young Adult
  • Thrombosis
  • Stroke
  • Prosthesis Failure
  • Prosthesis Design
  • Middle Aged
  • Kaplan-Meier Estimate
  • Intention to Treat Analysis
  • Humans
  • Heart-Assist Devices